Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system.
Connecta Therapeutics has raised $4.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2026.
Connecta Therapeutics's investors include Inveready, Clave Capital, Centre for the Development of Industrial Technology (CDTI), ENISA, EIC Accelerator.
Connecta Therapeutics is headquartered in Barcelona, Spain.
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system.
Connecta Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Connecta Therapeutics — Funding & Investors." VCBacked, September 10, 2026, https://www.vcbacked.co/company/connecta-therapeutics. Accessed October 20, 2026.
VCBacked. (2026). Connecta Therapeutics — Funding & Investors. Retrieved October 20, 2026, from https://www.vcbacked.co/company/connecta-therapeutics
{{cite web |title=Connecta Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/connecta-therapeutics |website=VCBacked |access-date=October 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated